GLP-1 RECEPTOR AGONISTS BEYOND OBESITY: EXPANDING HORIZONS IN CARDIOMETABOLIC, RENAL, AND NEUROLOGICAL DISEASE. ijms [Internet]. 2026 Apr. 30 [cited 2026 Aug. 7];6(4):849-55. Available from: https://www.academicpublishers.org/journals/index.php/ijms/article/view/13107